Ann: Change of Director's Interest Notice Amended, page-14

First 14 Last

Share
Profile

Follow
morganman

1,251 Posts.

131

06/07/22

13:31

Post #: 62400179
Share

Originally posted by aronoff1: ↑

Pretty nasty price action this morning after the director's unethical behaviour exposed. Certainly killed off the nice little rally that had just begun.

We all thought he was buying up half the company and turns out he was in reality day trading trying to make a quick buck! And pretty unsuccessful day trading at that. Ok he ‘net bought’ along the way but that’s not an excuse that justifies anything. And if he’s a hopeless day trader then why did he even do it? Trying to prop the price up? Drive it down to buy back cheaper? Create churn? Or the illegal ‘wash trade’ alluded to in the previous post?

Whatever the case he hasn’t done his shareholders any favours. Who wants to be in a stock with a dodgy director who basically lied to his shareholders and then springs nasty surprises like this one?

It also calls into question all the previous disclosures. Was he day trading along the way then too?

There has been blatant price manipulation in this stock on a daily basis. Price has been constantly pushed around this way and that by large fake orders in the depth that move the price then suddenly get pulled, hidden orders, bots jumping around.

Yes it’s standard practice but now that we know the director was possibly both the buyer AND the seller at any given time, and furthermore is not averse to indulging in illegal practices within his own stock, it raises the question … was he the one trying to manipulate the market to run the price up or down to suit himself?

I have personally given back heaps holding this stock through these last few nightmare weeks. It has been the only sizeable holding I've held onto and I’ve suffered a massive drawdown (in the multiple $10,000’s). The reason I continued to hold was because of the director supposedly continuing to ‘buy’. Now it turns out that many times I myself bought, I was likely buying from the director who was SELLING … while pretending to us all he was doing nothing but accumulating! Had I known the truth back then I would have ditched and saved myself a whole lot of money and aggravation.

It's a betrayal of his shareholders to indulge in this sort of behaviour for whatever selfish motives

Expand

Suspect he just paid the net loss to solidify tax benefits/implications available to him in that financial year - hence the net increase in position, despite the cost.

NC1 Price at posting: 77.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?

HAS

Hastings progressing Yangibana to production with lower costs

There are more pages in this discussion • 13 more messages in this thread...

First 14 Last

Add NC1 (ASX) to my watchlist

(20min delay)
Last 10.0¢		Change -0.010(9.09%)		Mkt cap ! $10.94M

Open	High	Low	Value	Volume
10.0¢	10.0¢	9.8¢	$15.78K	159.3K

Buyers (Bids)

No.	Vol.	Price($)
1	92	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
11.0¢	21883	1

View Market Depth

No.	Vol.	Price($)
1	92	0.100
1	33894	0.098
1	51546	0.097
1	104052	0.096
1	105147	0.095

Price($)	Vol.	No.
0.110	21883	1
0.120	17000	2
0.125	4999	1
0.130	10000	1
0.140	49869	2

Last trade - 15.17pm 30/09/2024 (20 minute delay)

NC1 (ASX) Chart

Ann: Change of Director's Interest Notice Amended, page-14

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?

Hastings progressing Yangibana to production with lower costs

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Change of Director's Interest Notice Amended, page-14

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?

Hastings progressing Yangibana to production with lower costs

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News